Which of the following clinical syndromes mentioned below is not an outcome following an exposure to Organophosphates
## Core Concept
Organophosphates are a class of chemicals commonly used in insecticides and chemical warfare agents. They act by inhibiting the enzyme **acetylcholinesterase**, leading to an accumulation of **acetylcholine** in the synaptic cleft and causing overstimulation of **cholinergic receptors**. This results in a variety of systemic effects.
## Why the Correct Answer is Right
The correct answer, , is not an outcome following exposure to organophosphates because organophosphates primarily cause an cholinergic crisis due to the inhibition of acetylcholinesterase. This leads to symptoms such as miosis, salivation, lacrimation, urination, diarrhea, and muscle fasciculations.
## Why Each Wrong Option is Incorrect
* **Option A:** is indeed an outcome following exposure to organophosphates. The inhibition of acetylcholinesterase leads to an accumulation of acetylcholine, causing overstimulation of muscarinic and nicotinic receptors, which results in symptoms such as muscle weakness and fasciculations.
* **Option B:** is also an outcome. Organophosphate poisoning can cause a range of systemic effects due to the overstimulation of cholinergic receptors, including cardiovascular effects.
* **Option C:** is an outcome as well. The cholinergic crisis caused by organophosphate poisoning can lead to respiratory failure due to bronchospasm, bronchial secretions, and weakness of respiratory muscles.
## Clinical Pearl / High-Yield Fact
A key clinical pearl is that the **intermediate syndrome** can occur in organophosphate poisoning, characterized by muscle weakness, cranial nerve palsies, and respiratory failure, typically occurring 24-96 hours after exposure. This highlights the importance of monitoring patients beyond the initial acute phase.
## Correct Answer: D.